InsiderTrades

Form 4 for IRD Opus Genetics, Inc.

Accepted 2026-09-11 16:09:50 ET · period of report 2026-09-09 · accession 0001140361-26-036347 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-09-11 16:09 2026-09-09 IRD Magrath George CEO, Dir M - OptEx $1.15 +392.2K 2.12M +23% +$451.0K
D 2026-09-11 16:09 2026-09-09 IRD Magrath George CEO, Dir F - Tax $5.97 -75.5K 2.05M -4% -$451.0K
D 2026-09-11 16:09 2026-09-09 IRD Magrath George CEO, Dir M - OptEx $0.00 -392.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-09 M A 392,157 $1.15 2,124,026 D — —
2 Common Common Stock 2026-09-09 F D 75,541 $5.97 2,048,485 D — — (F1) The Reporting Person paid the exercise price of the Warrant on a cashless basis. The Issuer withheld 75,541 shares, calculated in accordance with the terms of the Warrant, to pay the exercise price and issued the remaining 316,616 shares to the Reporting Person.
3 Derivative Warrant (right to buy) 2026-09-09 M D 392,157 $0.00 0 D $1.15 · — to 2030-03-25 392,157 Common Stock (F2) The Warrant was immediately exercisable upon its acquisition on March 24, 2025, subject to the Issuer's right to call the Warrant at any time beginning 30 days following the release of the Issuer's OPGx-BEST1 DUO-1001 Cohort 1 data upon achievement of (i) a volume weighted average price of the Issuer's Common Stock for 30 consecutive trading days of over $1.725 per share and (ii) the trading average daily volume for such 30 day period exceeding $150,000 per trading day.